Aptose Biosciences Inc (NASDAQ: APTO) is -90.96% lower on its value in year-to-date trading and has touched a low of $0.13 and a high of $2.68 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The APTO stock was last observed hovering at around $0.25 in the last trading session, with the day’s loss setting it 0.0%.
Currently trading at $0.25, the stock is 27.19% and -15.00% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.71 million and changing 0.48% at the moment leaves the stock -64.78% off its SMA200. APTO registered -90.10% loss for a year compared to 6-month loss of -69.13%. The firm has a 50-day simple moving average (SMA 50) of $0.2968 and a 200-day simple moving average (SMA200) of $0.71675.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 20.89% gain in the last 1 month and extending the period to 3 months gives it a -43.35%, and is 22.44% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 25.80% over the week and 13.69% over the month.
Aptose Biosciences Inc (APTO) has around 35 employees, a market worth around $13.67M and $0.00M in sales. Distance from 52-week low is 92.31% and -90.67% from its 52-week high. The company has generated returns on investments over the last 12 months (-3057.22%).
The EPS is expected to grow by 76.39% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
31.0 institutions hold shares in Aptose Biosciences Inc (APTO), with institutional investors hold 19.96% of the company’s shares. The shares outstanding are 59.52M, and float is at 55.85M with Short Float at 0.34%. Institutions hold 16.68% of the Float.
The top institutional shareholder in the company is DOHENY ASSET MANAGEMENT /CA with over 50550.0 shares valued at $0.32 million. The investor’s holdings represent 0.3849 of the APTO Shares outstanding. As of 2024-06-30, the second largest holder is CALDWELL SUTTER CAPITAL, INC. with 92.0 shares valued at $70.0 to account for 0.0007 of the shares outstanding.
Aptose Biosciences Inc (APTO) Insider Activity
The most recent transaction is an insider purchase by Rice William G., the company’s Chair, President & CEO. SEC filings show that Rice William G. bought 100,000 shares of the company’s common stock on Nov 25 ’24 at a price of $0.20 per share for a total of $20000.0. Following the purchase, the insider now owns 0.61 million shares.
